A CDC panel recommended Pfizer Covid-19 boosters for seniors and some adults with underlying medical conditions, but not adults at high risk of exposure at work
A Centers for Disease Control and Prevention advisory panel recommended seniors, nursing-home residents and certain adults with underlying medical conditions should receiveof Pfizer Inc.’s vaccine, a critical step toward outlining who should be eligible for the extra doses in the coming days.
The panel said people 65 and over as well as those 50 to 64 years with underlying medical conditions should receive a booster.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer Study of Covid-19 Vaccine in Pregnant Women Delayed by Slow EnrollmentPfizer wanted to study its Covid-19 vaccine in pregnant women, but then the shots became widely available; “It’s hard to enthusiastically recommend the study when you’ve got a vaccine out there,” says one doctor
Read more »
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older.
Read more »
Pfizer Covid-19 Booster Shouldn’t Be for Moderna, J&J Vaccine Recipients, Health Official SaysAn FDA official told vaccine experts reviewing who should get an additional dose of Pfizer’s Covid-19 vaccine that there isn’t enough data to allow for mixing and matching of different shots
Read more »
FDA backs Pfizer COVID-19 boosters for seniors and those at high riskThe FDA authorized Pfizer booster doses for Americans who are 65 and older, younger people with underlying health conditions and those in jobs that put them at high-risk for COVID-19.
Read more »
FDA authorizes Pfizer-BioNTech booster shot for elderly, people at high risk of severe Covid-19Pfizer-BioNTech booster shots are now authorized by the FDA for people 65 and older and for certain high-risk adult populations
Read more »